688166 博瑞医药
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.2237.9628.88012.38415.688
总资产报酬率 ROA (%)0.9933.7154.1786.28010.170
投入资产回报率 ROIC (%)1.1034.0204.5036.91011.259

边际利润分析
销售毛利率 (%)50.83457.51055.79463.01156.227
营业利润率 (%)1.19812.49816.12923.80324.609
息税前利润/营业总收入 (%)5.40515.44718.05124.77125.009
净利润/营业总收入 (%)3.02011.01414.70320.78322.573

收益指标分析
经营活动净收益/利润总额(%)138.754114.473105.52296.612102.124
价值变动净收益/利润总额(%)-39.807-11.026-8.0840.2323.892
营业外收支净额/利润总额(%)-5.430-1.965-0.7810.021-0.597

偿债能力分析
流动比率 (X)1.3971.5591.9952.3881.703
速动比率 (X)1.1121.2121.6212.0431.360
资产负债率 (%)51.13752.92051.95451.90841.351
带息债务/全部投入资本 (%)45.13247.21947.83648.34135.207
股东权益/带息债务 (%)108.267106.877105.609105.323181.201
股东权益/负债合计 (%)84.64187.39790.60490.579136.663
利息保障倍数 (X)1.2664.8438.82025.71645.853

营运能力分析
应收账款周转天数 (天)94.76585.71789.395119.63694.175
存货周转天数 (天)218.075234.266215.752229.802157.568